Update on management of skin and soft tissue infections in the emergency department

Michael S. Pulia, Mary R. Calderone, John R. Meister, Jamie Santistevan, Larissa S May

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Skin and soft tissue infections (SSTIs) are frequently treated in the emergency department (ED) setting. Recent studies provide critical new information that can guide new approaches to the diagnosis and treatment of SSTIs in the ED. Rapid polymerase chain reaction assays capable of detecting MRSA in approximately 1 h hold significant potential to improving antibiotic stewardship in SSTI care. Emergency ultrasound continues to demonstrate value in guiding appropriate management of SSTIs, including the early diagnosis of necrotizing infections. Since emerging in the 1990s, communityassociated methicillin-resistant Staphylococcus aureus (CA-MRSA) continues to increase in prevalence, and it represents a significant challenge to optimizing ED antibiotic use for SSTI management. Growing literature reinforces the current recommendation of incision and drainage without antibiotics for uncomplicated abscesses. Selecting antibiotics with CA-MRSA coverage is recommended when treating purulent SSTIs; however, it is generally not necessary in cases of nonpurulent cellulitis. Future advances in ED SSTI care may involve expansion of outpatient parenteral antimicrobial therapy protocols and the recent development of a novel, once weekly antibiotic with activity against MRSA.

Original languageEnglish (US)
Article number418
JournalCurrent Infectious Disease Reports
Volume16
Issue number9
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Soft Tissue Infections
Hospital Emergency Service
Skin
Methicillin-Resistant Staphylococcus aureus
Anti-Bacterial Agents
Cellulitis
Abscess
Early Diagnosis
Drainage
Emergencies
Outpatients
Polymerase Chain Reaction
Therapeutics
Infection

Keywords

  • Abscess
  • ABSSSI
  • Antibiotic stewardship
  • Antimicrobial
  • Blood cultures
  • CA-MRSA
  • Cellulitis
  • Emergency ultrasound
  • Home infusion therapy
  • Incision and drainage
  • Infection
  • Necrotizing fasciitis
  • PCR
  • Skin and soft tissue infection

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Update on management of skin and soft tissue infections in the emergency department. / Pulia, Michael S.; Calderone, Mary R.; Meister, John R.; Santistevan, Jamie; May, Larissa S.

In: Current Infectious Disease Reports, Vol. 16, No. 9, 418, 2014.

Research output: Contribution to journalReview article

Pulia, Michael S. ; Calderone, Mary R. ; Meister, John R. ; Santistevan, Jamie ; May, Larissa S. / Update on management of skin and soft tissue infections in the emergency department. In: Current Infectious Disease Reports. 2014 ; Vol. 16, No. 9.
@article{126e8a8fd1664ee992839fc2b40fda36,
title = "Update on management of skin and soft tissue infections in the emergency department",
abstract = "Skin and soft tissue infections (SSTIs) are frequently treated in the emergency department (ED) setting. Recent studies provide critical new information that can guide new approaches to the diagnosis and treatment of SSTIs in the ED. Rapid polymerase chain reaction assays capable of detecting MRSA in approximately 1 h hold significant potential to improving antibiotic stewardship in SSTI care. Emergency ultrasound continues to demonstrate value in guiding appropriate management of SSTIs, including the early diagnosis of necrotizing infections. Since emerging in the 1990s, communityassociated methicillin-resistant Staphylococcus aureus (CA-MRSA) continues to increase in prevalence, and it represents a significant challenge to optimizing ED antibiotic use for SSTI management. Growing literature reinforces the current recommendation of incision and drainage without antibiotics for uncomplicated abscesses. Selecting antibiotics with CA-MRSA coverage is recommended when treating purulent SSTIs; however, it is generally not necessary in cases of nonpurulent cellulitis. Future advances in ED SSTI care may involve expansion of outpatient parenteral antimicrobial therapy protocols and the recent development of a novel, once weekly antibiotic with activity against MRSA.",
keywords = "Abscess, ABSSSI, Antibiotic stewardship, Antimicrobial, Blood cultures, CA-MRSA, Cellulitis, Emergency ultrasound, Home infusion therapy, Incision and drainage, Infection, Necrotizing fasciitis, PCR, Skin and soft tissue infection",
author = "Pulia, {Michael S.} and Calderone, {Mary R.} and Meister, {John R.} and Jamie Santistevan and May, {Larissa S}",
year = "2014",
doi = "10.1007/s11908-014-0418-9",
language = "English (US)",
volume = "16",
journal = "Current Infectious Disease Reports",
issn = "1523-3847",
publisher = "Current Science, Inc.",
number = "9",

}

TY - JOUR

T1 - Update on management of skin and soft tissue infections in the emergency department

AU - Pulia, Michael S.

AU - Calderone, Mary R.

AU - Meister, John R.

AU - Santistevan, Jamie

AU - May, Larissa S

PY - 2014

Y1 - 2014

N2 - Skin and soft tissue infections (SSTIs) are frequently treated in the emergency department (ED) setting. Recent studies provide critical new information that can guide new approaches to the diagnosis and treatment of SSTIs in the ED. Rapid polymerase chain reaction assays capable of detecting MRSA in approximately 1 h hold significant potential to improving antibiotic stewardship in SSTI care. Emergency ultrasound continues to demonstrate value in guiding appropriate management of SSTIs, including the early diagnosis of necrotizing infections. Since emerging in the 1990s, communityassociated methicillin-resistant Staphylococcus aureus (CA-MRSA) continues to increase in prevalence, and it represents a significant challenge to optimizing ED antibiotic use for SSTI management. Growing literature reinforces the current recommendation of incision and drainage without antibiotics for uncomplicated abscesses. Selecting antibiotics with CA-MRSA coverage is recommended when treating purulent SSTIs; however, it is generally not necessary in cases of nonpurulent cellulitis. Future advances in ED SSTI care may involve expansion of outpatient parenteral antimicrobial therapy protocols and the recent development of a novel, once weekly antibiotic with activity against MRSA.

AB - Skin and soft tissue infections (SSTIs) are frequently treated in the emergency department (ED) setting. Recent studies provide critical new information that can guide new approaches to the diagnosis and treatment of SSTIs in the ED. Rapid polymerase chain reaction assays capable of detecting MRSA in approximately 1 h hold significant potential to improving antibiotic stewardship in SSTI care. Emergency ultrasound continues to demonstrate value in guiding appropriate management of SSTIs, including the early diagnosis of necrotizing infections. Since emerging in the 1990s, communityassociated methicillin-resistant Staphylococcus aureus (CA-MRSA) continues to increase in prevalence, and it represents a significant challenge to optimizing ED antibiotic use for SSTI management. Growing literature reinforces the current recommendation of incision and drainage without antibiotics for uncomplicated abscesses. Selecting antibiotics with CA-MRSA coverage is recommended when treating purulent SSTIs; however, it is generally not necessary in cases of nonpurulent cellulitis. Future advances in ED SSTI care may involve expansion of outpatient parenteral antimicrobial therapy protocols and the recent development of a novel, once weekly antibiotic with activity against MRSA.

KW - Abscess

KW - ABSSSI

KW - Antibiotic stewardship

KW - Antimicrobial

KW - Blood cultures

KW - CA-MRSA

KW - Cellulitis

KW - Emergency ultrasound

KW - Home infusion therapy

KW - Incision and drainage

KW - Infection

KW - Necrotizing fasciitis

KW - PCR

KW - Skin and soft tissue infection

UR - http://www.scopus.com/inward/record.url?scp=84906101671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906101671&partnerID=8YFLogxK

U2 - 10.1007/s11908-014-0418-9

DO - 10.1007/s11908-014-0418-9

M3 - Review article

AN - SCOPUS:84906101671

VL - 16

JO - Current Infectious Disease Reports

JF - Current Infectious Disease Reports

SN - 1523-3847

IS - 9

M1 - 418

ER -